Literature DB >> 17917113

Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain: neuroprotection versus neurotoxicity.

Sang R Kim1, Young C Chung, Eun S Chung, Keun W Park, So Y Won, E Bok, Eun S Park, Byung K Jin.   

Abstract

Transient receptor potential vanilloid subtype 1 (TRPV1), also known as vanilloid receptor 1 (VR1), is a nonselective cation channel that is activated by a variety of ligands, such as exogenous capsaicin (CAP) or endogenous anandamide (AEA), as well as products of lipoxygenases. Cannabinoid type 1 (CB1) receptor belongs to the G protein-coupled receptor superfamily and is activated by cannabinoids such as AEA and exogenous Delta-9-tetrahydrocannabinol (THC). TRPV1 and CB1 receptors are widely expressed in the brain and play many significant roles in various brain regions; however, the issue of whether TRPV1 or CB1 receptors mediate neuroprotection or neurotoxicity remains controversial. Furthermore, functional crosstalk between these two receptors has been recently reported. It is therefore timely to review current knowledge regarding the functions of these two receptors and to consider new directions of investigation on their roles in the brain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917113     DOI: 10.1007/s12035-007-0030-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  110 in total

1.  Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

Authors:  J J Rodriguez; K Mackie; V M Pickel
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

Review 2.  The TRP channels, a remarkably functional family.

Authors:  Craig Montell; Lutz Birnbaumer; Veit Flockerzi
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

3.  Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity.

Authors:  M E Abood; G Rizvi; N Sallapudi; S D McAllister
Journal:  Neurosci Lett       Date:  2001-08-31       Impact factor: 3.046

4.  Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.

Authors:  P Mailleux; J J Vanderhaeghen
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

5.  Functional vanilloid receptors in cultured normal human epidermal keratinocytes.

Authors:  Kaori Inoue; Schuichi Koizumi; Shigeyoshi Fuziwara; Sumiko Denda; Kazuhide Inoue; Mitsuhiro Denda
Journal:  Biochem Biophys Res Commun       Date:  2002-02-15       Impact factor: 3.575

Review 6.  Implication of cannabinoids in neurological diseases.

Authors:  Angela Alsasua del Valle
Journal:  Cell Mol Neurobiol       Date:  2006-05-12       Impact factor: 5.046

7.  Interacting effects of capsaicin and anandamide on intracellular calcium in sensory neurones.

Authors:  E Szöke; Z Balla; L Csernoch; G Czéh; J Szolcsányi
Journal:  Neuroreport       Date:  2000-06-26       Impact factor: 1.837

Review 8.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

9.  Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells.

Authors:  Gautham K Rao; Wei Zhang; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2004-02-13       Impact factor: 4.962

Review 10.  The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

Authors:  Julián Romero; Isabel Lastres-Becker; Rosario de Miguel; Fernando Berrendero; José A Ramos; Javier Fernández-Ruiz
Journal:  Pharmacol Ther       Date:  2002-08       Impact factor: 12.310

View more
  13 in total

1.  Short-term increases in transient receptor potential vanilloid-1 mediate stress-induced enhancement of neuronal excitation.

Authors:  Carl Weitlauf; Nicholas J Ward; Wendi S Lambert; Tatiana N Sidorova; Karen W Ho; Rebecca M Sappington; David J Calkins
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 2.  Research progress in transient receptor potential vanilloid 1 of sensory nervous system.

Authors:  Da-Lu Liu; Wen-Ting Wang; Jun-Ling Xing; San-Jue Hu
Journal:  Neurosci Bull       Date:  2009-08       Impact factor: 5.203

3.  Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress.

Authors:  Rebecca M Sappington; Tatiana Sidorova; Nicholas J Ward; Rohini Chakravarthy; Karen W Ho; David J Calkins
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

Review 4.  Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.

Authors:  Armen N Akopian; Nikita B Ruparel; Nathaniel A Jeske; Amol Patwardhan; Kenneth M Hargreaves
Journal:  Trends Pharmacol Sci       Date:  2008-12-11       Impact factor: 14.819

5.  A putative 'pre-nervous' endocannabinoid system in early echinoderm development.

Authors:  G A Buznikov; L A Nikitina; V V Bezuglov; M E Y Francisco; G Boysen; I N Obispo-Peak; R E Peterson; E R Weiss; H Schuel; B R S Temple; A L Morrow; J M Lauder
Journal:  Dev Neurosci       Date:  2009-11-12       Impact factor: 2.984

6.  Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection.

Authors:  Nicholas J Ward; Karen W Ho; Wendi S Lambert; Carl Weitlauf; David J Calkins
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

Review 7.  The Endocannabinoid Signaling System in the CNS: A Primer.

Authors:  Cecilia J Hillard
Journal:  Int Rev Neurobiol       Date:  2015-11-06       Impact factor: 3.230

Review 8.  Drug-induced hypothermia in stroke models: does it always protect?

Authors:  Meijuan Zhang; Haiying Wang; Jinbing Zhao; Cong Chen; Rehana K Leak; Yun Xu; Peter Vosler; Jun Chen; Yanqin Gao; Feng Zhang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

Review 9.  Epoxyeicosanoid signaling in CNS function and disease.

Authors:  Jeffrey J Iliff; Jia Jia; Jonathan Nelson; Toru Goyagi; Judy Klaus; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-06-21       Impact factor: 3.072

10.  Oleoylethanolamide Delays the Dysfunction and Death of Purkinje Cells and Ameliorates Behavioral Defects in a Mouse Model of Cerebellar Neurodegeneration.

Authors:  Ester Pérez-Martín; Rodrigo Muñoz-Castañeda; Marie-Jo Moutin; Carmelo A Ávila-Zarza; José M Muñoz-Castañeda; Carlos Del Pilar; José R Alonso; Annie Andrieux; David Díaz; Eduardo Weruaga
Journal:  Neurotherapeutics       Date:  2021-04-07       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.